D.S. Tromp et al. / Inorganica Chimica Acta 327 (2002) 90–97
95
4.3. Synthesis of [Pt0(diazadiene)(p2-alkene)]
compounds
4.3.5. (|-N,|-N%-5,8-Diaza-dodeca-5,7-diene)-
(p2-(E)-dimethylbut-2-ene-1,4-dioate)platinum(0) (2bx)
1H NMR (CDCl3): l 8.74 (s, 2H, NꢁCH), 8.74 (d, 2H,
3J(195Pt–1H)=58.5 Hz, NꢁCH), 4.05 (m, 4H, NCH2),
3.88 (s, 2H, HCꢁCH), 3.88 (d, 2H, 2J(195Pt–1H)=87 Hz,
HCꢁCH), 3.61 (s, 6H, OCH3), 2.03 (m, 4H, NCH2CH2),
1.38 (s, 4H, CH2CH3), 0.97 (t, 6H, CH2CH3).
4.3.1. A. Using Pt(DBA)2 or Pt(dipDBA)2
An amount of 1.0 equiv. of Pt0 precursor and 1.0–1.5
equiv. of the appropriate alkene (DMFU, MA or FN)
were stirred in dry diethyl ether at 20 °C under N2 for
10 min. An amount of 1 equiv. of the diazadiene ligand
was then added in small portions to this solution. After
stirring at 20 °C during 12–24 h, the reaction mixture
was filtered over Celite, the solvent evaporated and the
residue washed several times with pentane. The complex
was then purified by column chromatography on Al2O3
(deactivated with 7% H2O, eluting with toluene, followed
by dichloromethane) and evaporation of the solvent.
4.3.6. (|-N,|-N%-3,6-Diaza-2,2,7,7-tetramethyl-octa-
3,5-diene)(p2-(E)-dimethylbut-2-ene-1,4-dioate)-
platinum(0) (2cx)
1H NMR (CDCl3): l 8.92 (s, 2H, NꢁCH), 8.92 (d,
3J(195Pt–1H)=53 Hz, 2H, NꢁCH), 3.79 (s, 2H,
HCꢁCH), 3.79 (d2, J(195Pt–1H)=73.2 Hz, 2H, HCꢁCH),
3.58 (s, 6H, OCH3), 1.57 (s, 18H, CH3(t-Bu)). 13C NMR
(CDCl3): l 177.9 (CꢁO), 159.2 (CꢁN), 65.3 (C(CH3)3),
50.9 (OCH3), 30.0 (C(CH3)3), 25.7 (CꢁC), 25.7 (d,
J(195Pt–1H)=412.5 Hz, CꢁC).
4.3.2. B. Using Pt(NBE)3 or Pt(COD)2
The same procedure as above was followed up to and
including the addition of diazadiene, but using 1.0–1.1
equiv. of the alkene. After a reaction time of 1–2 h, the
solvent was evaporated in vacuo and the residue was
washed once with a small amount of pentane and dried
to yield the pure products.
4.3.7. (|-N,|-N%-1,4-Di(4-methylphenyl)-
1,4-diaza-1,3-butadiene)(p2-(E)-dimethylbut-2-ene-
1,4-dioate)platinum(0) (2dx)
1
FAB MS: M+=576.1. H NMR (CDCl3): l 9.22 (s,
2H, NꢁCH), 9.22 (d, 3J(195Pt–1H)=52 Hz, 2H, NꢁCH),
7.62 (d, J(1H–1H)=8.7 Hz, 8H, p-tolylH), 7.05 (d,
J(1H–1H)=8.1 Hz, 8H, p-tolylH), 4.01 (s, 2H,
4.3.3. (|-N,|-N%-3,6-Diaza-2,7-dimethyl-octa-
3,5-diene)(p2-(E)-dimethylbut-2-ene-1,4-dioate)-
platinum(0) (2ax)
2
HCꢁCH), 4.01 (d, J(195Pt–1H)=84 Hz, 2H, HCꢁCH),
FAB MS: M+=480.1. IR (KBr. cm−1): 1547 (CꢁN).
1H NMR (CDCl3): l 8.90 (s, 2H, NꢁCH), 8.90 (d,
3J(195Pt–1H)=55.5 Hz, 2H, NꢁCH), 4.05 (m, 2H, CH(i-
3.52 (s, 6H, CH3(COOMe)), 2.36 (s, 6H, CH3C6H4).
4.3.8. (|-N,|-N%-1,4-Di(4-methylphenyl)-
2
Pr)), 3.85 (s, 2H, HCꢁCH), 3.85 (d, J(195Pt–1H)=86.4
1,4-diaza-1,3-butadiene)(p2-(E)-1,2-dicyano-ethene)-
platinum(0) (2dz)
Hz, 2H, HCꢁCH), 3.59 (s, 6H, OCH3), 1.60 (d, J(1H–
1H)=6 Hz, 6H, (CH3)2CH), 1.38 (d, J(1H–1H)=6.3 Hz,
6H, CH3(i-Pr)). 13C NMR (CDCl3): l 177.7 (CꢁO), 177.7
(d, 2J(195Pt–13C)=56 Hz, CꢁO), 160.3 (CꢁN), 64.7
1H NMR (CDCl3): l 9.16 (s, 2H, NꢁCH), 9.16 (d,
3J(195Pt–1H)=48 Hz, 2H, NꢁCH), 7.72 (d, J(1H–1H)=
8.1 Hz, 8H, p-tolylH), 7.23 (d, J(1H–1H)=9.9 Hz, 8H,
p-tolylH), 3.01 (s, 2H, HCꢁCH), 3.01 (d, 2J(195Pt–1H)=
89.4 Hz, 2H, HCꢁCH), 2.35 (s, 6H, CH3(p-tolyl)).
2
(CH3)2CH, 64.7 (d, J(195Pt–13C)=73 Hz, CH(CH3)2),
1
51.0 (OCH3), 25.4 (CꢁC), 25.4 (d, J(195Pt–13C)=399
3
Hz, CꢁC), 24.05 ((CH3)2CH), 24.05 (d, J(195Pt–13C)=
13.4 Hz, (CH3)2CH), 23.7 ((CH3)2-CH). Elemental anal-
ysis: Calc. for C14H24N2O4Pt (479.14): C, 35.07; H, 5.05;
N, 5.84. Found: C, 34.98; H, 5.12; N, 5.79%.
4.3.9. (|-N,|-N%-1,4-Di(4-methoxyphenyl)-1,4-
diaza-1,3-butadiene)(p2-(E)-dimethylbut-2-ene-1,4-
dioate)platinum(0) (2ex)
1H NMR (CDCl3): l 9.12 (s, 2H, NꢁCH), 9.12 (d,
3J(195Pt–1H)=52.2 Hz, 2H, NꢁCH), 7.72 (d,
J(1H–1H)=9 Hz, 4H, ArH), 6.73 (d, J(1H–1H)=9.3
Hz, 4H, ArH), 3.97 (s, 2H, HCꢁCH), 3.97 (d,
2J(195Pt–1H)=85.2 Hz, 2H, HCꢁCH), 3.83 (s, 6H,
OCH3), 3.54 (s, 6H, CH3(p-anisyl)).
4.3.4. (|-N,|-N%-3,6-Diaza-2,7-dimethyl-octa-
3,5-diene)(p2-(Z)-but-2-ene-1,4-dicarboxylic acid
anhydride)platinum(0) (2ay)
1H NMR (CDCl3): l 8.86 (s, 2H, NꢁCH), 8.86 (d,
3J(195Pt–1H)=60.9 Hz, 2H, NꢁCH), 4.08 (m, 2H,
CH(CH3)2), 3.76 (s, 2H, HCꢁCH), 3.76 (d 3J(195Pt–
1H)=81 Hz, 2H, HCꢁCH), 1.56 (d, J(1H–1H)=6.3 Hz,
6H (CH3)2CH), 1.49 (d, J(1H–1H)=6.3 Hz, 6H,
(CH3)2CH). 13C NMR (CDCl3): l 175.4 (CꢁO), 161.3
(CꢁN), 65.5 ((CH3)2CH), 24.8 ((CH3)2CH), 24.4 (CꢁC),
24.4 (d, J(195Pt–13C)=237 Hz, CꢁC), 23.6 ((CH3)2CH).
Elemental analysis: Calc. C14H24N2O4Pt (479.14): C,
33.26; H, 4.19; N, 6.46. Found: C, 30.25; H, 3.64; N,
5.71%.
4.3.10. (|-N,|-N%-1,4-Dicyclopropyl)-1,4-
diaza-2,3-dimethyl-1,3-butadiene)(p2-(E)-dimethylbut-2-
ene-1,4-dioate)platinum(0) (2fx)
1
FAB MS: M+=504.1. H NMR (C6D6): l 4.17 (s,
2H, HCꢁCH), 4.17 (d, 2J(195Pt–1H)=81.3 Hz, 2H,
HCꢁCH), 3.60 (s, 6H, OCH3), 2.45 (m, 2H,
CH(cyclopr.)), 2.09 (m, 4H, CH2(cyclopr.)), 1.66 (m,
4H, H2(cyclopr.)), 0.98 (s, 6H, NꢁC(CH)3). 13C NMR